Course

Meningioma Update - Pathology, Molecular, Surgical, Therapeutic and Quality of Life

Tuesday, June 6, 2023

1:45 PM – 4:15 PM MST

Location:CC: Edward Beatty

Audience:

Adult Neurologist, Neurosurgeon, Neuroradiologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Basic (Resident, New Information), Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Case studies, Discussion group/peer exchange/user groups, Lecture/plenary method, Question and answer sessions

CanMEDs Roles:

Medical Expert, Scholar, Communicator, Collaborator, Leader, Health Advocate, Professional

Chair(s)

GZ

Gelareh Zadeh

Speaker(s)

This session will focus on updates in:
Current standards to surgical approaches to meningiomas in the endoscopic era
Understanding outcomes of Grade 3 Meningiomas: International study
Advances WHO Molecular Pathology of Meningiomas,
Implications of CDKN2A in understanding Meningioma behaviour and clinical management
How to apply methylation signatures to predicting outcome of Meningiomas
Quality of life outcomes of Meningiomas
Tumor Board Review of Cases to Apply Current Molecular Knowledge to Clinical Management

Learning Objectives:

Know Updated Molecular Classification of Meningiomas and Implication of CDKN2A
How to Integrate Molecular Knowledge in Management of Meningiomas
Understand Outcome of Grade 3 Meningiomas
Quality of Life Outcomes of Meningiomas
Application of Methylation Based Predictors for Meningiomas in Decision Making
Consolidate Information that Informs Next Generation Research

Presentations:

1:45 PM – 2:05 PM MST

Update on WHO 2022 Classification of Meningiomas
Speaker: Stephen Yip
2:05 PM – 2:30 PM MST

Principles of Meningioma Surgery: Considerations for Endoscopic Resection
Speaker: Peter Gooderham
2:30 PM – 2:50 PM MST

Integration of Methylation Data in Management of Meningiomas
Speaker: Farshad Nassiri
2:50 PM – 3:15 PM MST

Tumor Board
Speaker: Gelareh Zadeh
Speaker: Stephen Yip
Speaker: Serge Makarenko
Speaker: Michael Cusimano
3:15 PM – 3:30 PM MST

Discussion
Speaker: Gelareh Zadeh
3:30 PM – 3:50 PM MST

Grade 3 Meningiomas: An International Consortium Report on Survival and Outcome
Speaker: Alexander Rebchuk
3:50 PM – 4:10 PM MST

Landscape of CDKN2A in Meningiomas: Implications on WHO Classification and Therapeutics
Speaker: Justin Wang
4:10 PM – 4:15 PM MST

Q&A
Speaker: Gelareh Zadeh